Literature DB >> 19727885

Effects of the Sri Lankan medicinal plant, Salacia reticulata, in rheumatoid arthritis.

Yuusuke Sekiguchi1, Hiroshi Mano, Sachie Nakatani, Jun Shimizu, Masahiro Wada.   

Abstract

Salacia reticulata is a native plant of Sri Lanka. In the traditional medicine of Sri Lanka and India, Salacia reticulata bark is considered orally effective in the treatment of rheumatism, gonorrhea, skin disease and diabetes. We have investigated, both in vivo and in vitro, whether the leaf of Salacia reticulata (SRL) can ameliorate collagen antibody-induced arthritis (CAIA) in mice as the rheumatoid arthritis (RA) model. The mice were fed a lard containing chow diet (AIN-93G) or the same diet containing 1% (w/w) SRL powder. All mice were bred for 23 days. On day 7 or 14 after LPS injection, mice were killed, and tissue and blood samples were collected. Histological analysis was performed, and serum levels of inflammatory mediators and the mRNA levels of inflammation-related genes and osteoclast-related genes were measured. SRL treatment ameliorated the rapid initial paw swelling, inflammatory cells infiltration, skeletal tissues damage, osteoclast activation and the mRNA levels for osteoclast-related genes compared with the CAIA mice. However, the serum and mRNA levels of inflammatory mediators did not differ between the CAIA mice and the SRL-treated mice. SRL might reduce the inflammatory cells induction and skeletal tissue degradation by CAIA by the regulating osteoclastogenesis.

Entities:  

Keywords:  CAIA; Osteoclast; Pannus; RANKL; Rheumatoid arthritis; Salacia reticulata

Year:  2009        PMID: 19727885      PMCID: PMC2820195          DOI: 10.1007/s12263-009-0144-3

Source DB:  PubMed          Journal:  Genes Nutr        ISSN: 1555-8932            Impact factor:   5.523


  30 in total

1.  Cytokines in chronic inflammatory arthritis. III. Rheumatoid arthritis monocytes are not unusually sensitive to gamma-interferon, but have defective gamma-interferon-mediated HLA-DQ and HLA-DR induction.

Authors:  V Bergroth; N J Zvaifler; G S Firestein
Journal:  Arthritis Rheum       Date:  1989-09

2.  Novel transdermal photodynamic therapy using ATX-S10.Na(II) induces apoptosis of synovial fibroblasts and ameliorates collagen antibody-induced arthritis in mice.

Authors:  S Miyazawa; K Nishida; T Komiyama; Y Nakae; K Takeda; M Yorimitsu; A Kitamura; T Kunisada; A Ohtsuka; H Inoue
Journal:  Rheumatol Int       Date:  2005-10-12       Impact factor: 2.631

3.  Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis. A possible role for locally produced parathyroid hormone-related protein in the pathogenesis of rheumatoid arthritis.

Authors:  J L Funk; L A Cordaro; H Wei; J B Benjamin; D E Yocum
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

4.  Imbalanced expression of RANKL and osteoprotegerin mRNA in pannus tissue of rheumatoid arthritis.

Authors:  M Ainola; J Mandelin; M Liljeström; Y T Konttinen; J Salo
Journal:  Clin Exp Rheumatol       Date:  2008 Mar-Apr       Impact factor: 4.473

5.  The identity of immunosuppressive components of the ethyl acetate extract and chloroform methanol extract (T2) of Tripterygium wilfordii Hook. F.

Authors:  X Tao; J J Cai; P E Lipsky
Journal:  J Pharmacol Exp Ther       Date:  1995-03       Impact factor: 4.030

6.  Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial.

Authors:  L H D van Tuyl; W F Lems; A E Voskuyl; P J S M Kerstens; P Garnero; B A C Dijkmans; M Boers
Journal:  Ann Rheum Dis       Date:  2008-07-14       Impact factor: 19.103

7.  Aggravating effect of ergometrine on pyloric antral lesions in indomethacin-treated animals and stimulating effect of this drug on gastric acid secretion.

Authors:  M Maeda-Hagiwara; K Watanabe
Journal:  Jpn J Pharmacol       Date:  1981-12

8.  Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response.

Authors:  Jeffrey M Labasi; Nina Petrushova; Carol Donovan; Sandra McCurdy; Paul Lira; Mary M Payette; William Brissette; Joan R Wicks; Laurent Audoly; Christopher A Gabel
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

9.  Imatinib mesylate inhibits osteoclastogenesis and joint destruction in rats with collagen-induced arthritis (CIA).

Authors:  Wataru Ando; Jun Hashimoto; Akihide Nampei; Hideki Tsuboi; Kosuke Tateishi; Takeshi Ono; Norimasa Nakamura; Takahiro Ochi; Hideki Yoshikawa
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.976

10.  Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment.

Authors:  Francesca Bobbio-Pallavicini; Claudia Alpini; Roberto Caporali; Stefano Avalle; Serena Bugatti; Carlomaurizio Montecucco
Journal:  Arthritis Res Ther       Date:  2004-04-26       Impact factor: 5.156

View more
  4 in total

1.  Anti-proliferative effects of Salacia reticulata leaves hot-water extract on interleukin-1β-activated cells derived from the synovium of rheumatoid arthritis model mice.

Authors:  Yuusuke Sekiguchi; Hiroshi Mano; Sachie Nakatani; Jun Shimizu; Kenji Kobata; Masahiro Wada
Journal:  BMC Res Notes       Date:  2012-04-26

2.  Mangiferin positively regulates osteoblast differentiation and suppresses osteoclast differentiation.

Authors:  Yuusuke Sekiguchi; Hiroshi Mano; Sachie Nakatani; Jun Shimizu; Aya Kataoka; Kana Ogura; Yoshifumi Kimira; Midori Ebata; Masahiro Wada
Journal:  Mol Med Rep       Date:  2017-06-12       Impact factor: 2.952

3.  Mediators of inflammation-induced bone damage in arthritis and their control by herbal products.

Authors:  Siddaraju M Nanjundaiah; Brian Astry; Kamal D Moudgil
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-07       Impact factor: 2.629

4.  Overload of the Temporomandibular Joints Accumulates γδ T Cells in a Mouse Model of Rheumatoid Arthritis: A Morphological and Histological Evaluation.

Authors:  Kohei Nagai; Takenobu Ishii; Tatsukuni Ohno; Yasushi Nishii
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.